Peripear Ltd 15418398 false 2025-02-01 2026-01-31 2026-01-31 The principal activity of the company is manufacture of medical instruments. Digita Accounts Production Advanced 6.30.9574.0 true 15418398 2025-02-01 2026-01-31 15418398 2026-01-31 15418398 core:CurrentFinancialInstruments 2026-01-31 15418398 core:CurrentFinancialInstruments core:WithinOneYear 2026-01-31 15418398 core:Non-currentFinancialInstruments core:AfterOneYear 2026-01-31 15418398 core:FurnitureFittingsToolsEquipment 2026-01-31 15418398 bus:SmallEntities 2025-02-01 2026-01-31 15418398 bus:AuditExemptWithAccountantsReport 2025-02-01 2026-01-31 15418398 bus:FilletedAccounts 2025-02-01 2026-01-31 15418398 bus:SmallCompaniesRegimeForAccounts 2025-02-01 2026-01-31 15418398 bus:RegisteredOffice 2025-02-01 2026-01-31 15418398 bus:Director1 2025-02-01 2026-01-31 15418398 bus:Director2 2025-02-01 2026-01-31 15418398 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 15418398 core:FurnitureFittingsToolsEquipment 2025-02-01 2026-01-31 15418398 core:OfficeEquipment 2025-02-01 2026-01-31 15418398 countries:England 2025-02-01 2026-01-31 15418398 2024-02-01 2025-01-31 15418398 2025-01-31 15418398 core:CurrentFinancialInstruments 2025-01-31 15418398 core:CurrentFinancialInstruments core:WithinOneYear 2025-01-31 15418398 core:Non-currentFinancialInstruments core:AfterOneYear 2025-01-31 iso4217:GBP xbrli:pure

Registration number: 15418398

Peripear Ltd

Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 January 2026

 

Peripear Ltd

Contents

Company Information

1

Directors' Report

2

Abridged Balance Sheet

3 to 4

Notes to the Unaudited Abridged Financial Statements

5 to 7

 

Peripear Ltd

Company Information

Directors

Eviatar Natan

Nina van Schaick

Registered office

105 Godstow Road
Wolvercote
Oxford
OX2 8PF

 

Peripear Ltd

Directors' Report for the Year Ended 31 January 2026

The directors present their report and the abridged financial statements for the year ended 31 January 2026.

Directors of the company

The directors who held office during the year were as follows:

Eviatar Natan

Nina van Schaick

Principal activity

The principal activity of the company is manufacture of medical instruments.

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 21 July 2026 and signed on its behalf by:
 

.........................................
Eviatar Natan
Director

 

Peripear Ltd

(Registration number: 15418398)
Abridged Balance Sheet as at 31 January 2026

Note

2026
£

2025
£

Fixed assets

 

Tangible assets

5

1,611

-

Current assets

 

Debtors

4,243

2,476

Cash at bank and in hand

 

36,033

19,836

 

40,276

22,312

Prepayments and accrued income

 

1,227

-

Creditors: Amounts falling due within one year

(19,072)

(3,876)

Net current assets

 

22,431

18,436

Total assets less current liabilities

 

24,042

18,436

Creditors: Amounts falling due after more than one year

(192,911)

-

Accruals and deferred income

 

(15,705)

(12,420)

Net (liabilities)/assets

 

(184,574)

6,016

Capital and reserves

 

Called up share capital

3

3

Share premium reserve

113,439

48,090

Other reserves

114,392

26,000

Retained earnings

(412,408)

(68,077)

Shareholders' (deficit)/funds

 

(184,574)

6,016

For the financial year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet and have elected to take the option not to file the Profit and Loss Account in accordance with Section 444 of the Companies Act 2006

 

Peripear Ltd

(Registration number: 15418398)
Abridged Balance Sheet as at 31 January 2026

Approved and authorised by the Board on 21 July 2026 and signed on its behalf by:
 

.........................................

Eviatar Natan

Director

 

Peripear Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 January 2026

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
105 Godstow Road
Wolvercote
Oxford
OX2 8PF
United Kingdom

These financial statements were authorised for issue by the Board on 21 July 2026.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

 

Peripear Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 January 2026

Asset class

Depreciation method and rate

Furniture, Fittings and Equipment

25% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2025 - 2).

 

Peripear Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 January 2026

4

Loss before tax

Arrived at after charging/(crediting)

2026
£

2025
£

Depreciation expense

368

-

5

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

Additions

1,979

1,979

At 31 January 2026

1,979

1,979

Depreciation

Charge for the year

368

368

At 31 January 2026

368

368

Carrying amount

At 31 January 2026

1,611

1,611